Escitalopram: efficacy and tolerability in the treatment of depression-Reference-Cited by-同舟云学术

Escitalopram: efficacy and tolerability in the treatment of depression

Published:2002-11 Issue:11 Volume:63 Page:668-671
ISSN:1462-3935
Container-title:Hospital Medicine
language:en
Short-container-title:Hospital Medicine

Author:

Baldwin David S¹

Affiliation:

1. Community Clinical Sciences Research Division, Faculty of Medicine, Health and Biological Sciences, University Department of Mental Health, University of Southampton, Royal South Hants Hospital, Southampton SO14 0YG

Publisher

Mark Allen Group

Subject

General Veterinary

Link

http://www.magonlinelibrary.com/doi/pdf/10.12968/hosp.2002.63.11.1912

Reference16 articles.

1. Putting chirality to work: the strategy of chiral switches

2. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines

3. Selective serotonin re-uptake inhibitors in anxiety disorders: room for improvement

4. Enantiomers' potential in psychopharmacology—a critical analysis with special emphasis on the antidepressant escitalopram

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selective Serotonin Reuptake Inhibitors within Cells: Temporal Resolution in Cytoplasm, Endoplasmic Reticulum, and Membrane;The Journal of Neuroscience;2023-03-03

2. Milnacipran Ameliorates Executive Function Impairments following Frontal Lobe Traumatic Brain Injury in Male Rats: A Multimodal Behavioral Assessment;Journal of Neurotrauma;2023-01-01

3. Selective Serotonin Reuptake Inhibitors Within Cells: Temporal Resolution in Cytoplasm, Endoplasmic Reticulum, and Membrane;2022-08-12

4. Efficacy of escitalopram monotherapy in the treatment of major depressive disorder;Medicine;2017-09

5. Für jeden Patienten den optimalen Wirkstoff finden;NeuroTransmitter;2012-12